Guilherme Yazbek

Guilherme Yazbek

Auto-generated profile, based on publicly available information

Guilherme Yazbek

Department of Vascular Surgery, Hospital A.C. Camargo, São Paulo - Brazil

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
GYGuilherme Yazbek
Guilherme Yazbek
NWNelson Wolosker
Nelson Wolosker
JCJosé Ribas Milanez de Campos
José Ribas Milanez de Campos
PKPaulo Kauffman
Paulo Kauffman
AIAugusto Ishy
Augusto Ishy
PPPedro Puech-Leão
Pedro Puech-Leão

1 August 2009 in Clinics
Verified
Journal Article
Open access
PDF file
GYGuilherme Yazbek
Guilherme Yazbek
NWNelson Wolosker
Nelson Wolosker
PKPaulo Kauffman
Paulo Kauffman
JCJosé Ribas Milanez de Campos
José Ribas Milanez de Campos
PPPedro Puech-Leão
Pedro Puech-Leão
FJFábio Biscegli Jatene
Fábio Biscegli Jatene
To compare two surgical techniques (denervation levels) for sympathectomy using video-assisted thoracoscopy to treat palmar hyperhidrosis in the long-term. From May 2003 to June 2006, 60 patients with palmar hyperhidrosis were prospectively randomized for video-assisted thoracoscopic sympathectomy at the T2 or T3 ganglion level. They were followed for a mean of 20 months and were evaluated regarding their degree of improvement of palmar hyperhidrosis, incidence and severity of compensatory hyperhidrosis and its evolution over time, and quality of life. Fifty-nine cases presented resolution of the palmar hyperhidrosis. One case of therapeutic failure occurred in the T3 group. Most of the patients presented an improvement in palmar hyperhidrosis, without any difference between the groups. Twenty months later, all patients in both groups presented some degree of compensatory hyperhidrosis but with less severity in the T3 group (p = 0.007). Compensatory hyperhidrosis developed in most patients during the first month after the operation, with incidence and severity that remained stable over time. An improvement in quality of life was seen starting from the first postoperative evaluation but without any difference between the groups. This improvement was maintained until the end of the follow-up. Both techniques were effective for treating palmar hyperhidrosis. The most frequent complication was compensatory hyperhidrosis, which presented stable incidence and severity over the study period. Sympathectomy at the T3 level presented compensatory hyperhidrosis with less severity. Nevertheless, the improvement in quality of life was similar between the groups.

1 May 2013 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
LFLaert Oliveira de Andrade Filho
Laert Oliveira de Andrade Filho
SKSérgio Kuzniec
Sérgio Kuzniec
NWNelson Wolosker
Nelson Wolosker
GYGuilherme Yazbek
Guilherme Yazbek
PKPaulo Kauffman
Paulo Kauffman
JCJosé Ribas Milanez de Campos
José Ribas Milanez de Campos

1 February 2008 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
NWNelson Wolosker
Nelson Wolosker
GYGuilherme Yazbek
Guilherme Yazbek
AIAugusto Ishy
Augusto Ishy
JCJosé Ribas M. de Campos
José Ribas M. de Campos
PKPaulo Kauffman
Paulo Kauffman
PPPedro Puech-Leão
Pedro Puech-Leão
We compared the results from a video-assisted thoracoscopic sympathectomy (VTS) at the T4 denervation level with those from a VTS at the T3 level for the treatment of palmar hyperhydrosis (PH). Seventy patients with PH were prospectively followed for VTS at the T3 or T4 denervation levels for 6 months. The end points of this study were: absence of PH, compensatory hyperhydrosis (CH), and quality-of-life assessment. Sixty-seven patients reported a complete resolution of PH after surgery. One failure occurred in the T3 group and 2 in the T4 group. When anhydrosis was obtained, we noticed totally dry hands in 26 patients in the T3 group and 6 patients in the T4 group. The other 27 patients in the T4 group and 8 in the T3 group maintained a small level of sweating and were also considered to be therapeutic successes. At 6 months, 25 patients in the T4 group had some degree of CH (71.42%) and all patients in the T3 group (100%), though the T4 group had a lower degree of severity of CH at the 6-month follow-up (P < 0.05). After the operation, quality of life was improved similarly in both groups. VTS at either the T3 or T4 level provides an effective treatment for PH. VTS at the T4 level is associated with a less severe form of CH. Despite the occurrence of CH, patients' quality of life is significantly improved following VTS at the T3 or T4 levels. For this reason, the T4 resection can now be used as a treatment for PH.

19 June 2011 in Clinical Autonomic Research
Verified
Journal Article
Closed access
PDF file
NWNelson Wolosker
Nelson Wolosker
JCJose R. de Campos
Jose R. de Campos
PKPaulo Kauffman
Paulo Kauffman
SNSamantha Neves
Samantha Neves
GYGuilherme Yazbek
Guilherme Yazbek
PPPedro Puech-Leão
Pedro Puech-Leão

1 May 2010 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
NWNelson Wolosker
Nelson Wolosker
GYGuilherme Yazbek
Guilherme Yazbek
JCJosé Ribas Milanez de Campos
José Ribas Milanez de Campos
MMMarco Antonio Munia
Marco Antonio Munia
PKPaulo Kauffman
Paulo Kauffman
PPPedro Puech-Leao
Pedro Puech-Leao